BGC vs CME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Feb 02, 2026
BGC
61.8
AI Score
VS
CME Wins
CME
64.8
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | BGC | CME | Winner |
|---|---|---|---|
| Revenue | 2.19B | 4.87B | CME |
| Net Income | 140.59M | 2.89B | CME |
| Net Margin | 6.4% | 59.3% | CME |
| ROE | 14.6% | 10.2% | BGC |
| ROA | 2.4% | 1.5% | BGC |
| Total Assets | 5.83B | 187.14B | CME |
| Cash | 774.94M | 2.45B | CME |
| Free Cash Flow | 197.74M | 3.09B | CME |
Frequently Asked Questions
Based on our detailed analysis, CME is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.